Sutro Biopharma (STRO) Research & Development (2017 - 2026)
Sutro Biopharma (STRO) reported Research & Development of $31.7 million for Q2 2026, down 17.3% from $38.33 million a year earlier.
Powered by 
Analysis
Sutro Biopharma (STRO) Research & Development (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Sutro Biopharma's Research & Development came in at $146.52 million, down 34.3% year-over-year; for FY2025, it was $166.42 million, down 34.0% from FY2024.
- Research & Development has a five-year compound annual growth rate of 16.7% (FY2020 to FY2025).
- By year, Research & Development came in at $252.04 million in FY2024 (+39.7%), $180.43 million in FY2023 (+31.5%), $137.17 million in FY2022 (+31.4%) and $104.4 million in FY2021 (+35.7%).
- The Q2 2026 figure ranks as the lowest quarterly Research & Development since Q1 2022.
- Year over year, Research & Development gained in two of the last seven quarters, with an average decline of 11.6%.
- The high point for year-over-year Research & Development in five years was Q2 2024 (growth of 49.1%); the low point was Q4 2025 (a decline of 48.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Sutro Biopharma | 265.72 Mn | -412.78 Mn | - | 31.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.70 Mn |
| Dec 31, 2025 | 36.64 Mn |
| Sep 30, 2025 | 39.85 Mn |
| Jun 30, 2025 | 38.33 Mn |
| Mar 31, 2025 | 51.60 Mn |
| Dec 31, 2024 | 71.04 Mn |
| Sep 30, 2024 | 62.11 Mn |
| Jun 30, 2024 | 62.02 Mn |
| Mar 31, 2024 | 56.88 Mn |
| Dec 31, 2023 | 53.77 Mn |
| Sep 30, 2023 | 45.67 Mn |
| Jun 30, 2023 | 41.59 Mn |
| Mar 31, 2023 | 39.40 Mn |
| Dec 31, 2022 | 43.14 Mn |
| Sep 30, 2022 | 31.71 Mn |
| Jun 30, 2022 | 32.33 Mn |
| Mar 31, 2022 | 29.99 Mn |
| Dec 31, 2021 | 29.93 Mn |
| Sep 30, 2021 | 26.60 Mn |
| Jun 30, 2021 | 25.31 Mn |
API Access
Sutro Biopharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=STRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "STRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=STRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();